Department of Medicine, Division of General Internal Medicine, Duke Center for Palliative Care, Duke University, Durham, NC, USA.
Duke Cancer Institute, Duke University, Durham, NC, USA.
Expert Rev Hematol. 2020 Mar;13(3):223-231. doi: 10.1080/17474086.2020.1728248. Epub 2020 Feb 17.
: Palliative care is specialized health care focused on improving the quality of life amid serious illness. Patients with hematologic malignancies have significant needs that could be addressed by a multidisciplinary palliative care team, but the integration of palliative care into hematology is far behind that of solid tumor oncology.: This article considers what is known about the palliative care needs of hematologic malignancy patients, shows how the multidisciplinary palliative care team could improve their care, and explores how barriers to this relationship might be overcome. The evidence to support this review comes from review of recent, relevant papers known to the authors as well as PubMed searches of additional relevant articles over the past 3 years.: Further cultivating this relationship requires us to thoughtfully integrate the multidisciplinary palliative care team to respond to each patient's specific disease and needs, and do so at the ideal time, to maximize benefits.
缓和医疗是一种专注于改善重病患者生活质量的专业医疗。患有血液恶性肿瘤的患者有很大的需求，可以通过多学科的缓和医疗团队来满足，但缓和医疗在血液学中的融入程度远远落后于实体肿瘤肿瘤学。本文考虑了血液恶性肿瘤患者的缓和医疗需求，展示了多学科缓和医疗团队如何改善他们的护理，并探讨了如何克服这一关系的障碍。这篇综述的证据来自于作者所熟知的最近相关论文的回顾，以及过去 3 年来对其他相关文章的 PubMed 搜索。进一步培养这种关系需要我们深思熟虑地整合多学科的缓和医疗团队，以满足每个患者特定的疾病和需求，并在理想的时间这样做，以最大限度地发挥效益。
